Back to Journals » OncoTargets and Therapy

OncoTargets and Therapy

ISSN: 1178-6930

Journal Articles:

- 6,337 records -

JUND Promotes Tumorigenesis via Specifically Binding on Enhancers of Multiple Oncogenes in Cervical Cancer

Zhou J, Mo J, Tan C, Xie F, Liang J, Huang W

OncoTargets and Therapy 2023, 16:347-357

Published Date: 31 May 2023

The Role of Neutrophil-to-Lymphocyte Ratio in Advanced EGFR-Mutant NSCLC Patients Treated with First-Line Osimertinib

Chen KC, Huang YH, Hsu KH, Tseng JS, Chang GC, Yang TY

OncoTargets and Therapy 2023, 16:317-326

Published Date: 17 May 2023

KDM5C Expedites Lung Cancer Growth and Metastasis Through Epigenetic Regulation of MicroRNA-133a [Retraction]

Zhang Q, Xu L, Wang J, Zhu X, Ma Z, Yang J, Li J, Jia X, Wei L

OncoTargets and Therapy 2023, 16:315-316

Published Date: 15 May 2023

LINC00565 Enhances Proliferative Ability in Endometrial Carcinoma by Downregulating KLF9 [Retraction]

Yin X, Li X, Feng G, Qu Y, Wang H

OncoTargets and Therapy 2023, 16:313-314

Published Date: 15 May 2023

KIF4A Promotes Clear Cell Renal Cell Carcinoma (ccRCC) Proliferation in vitro and in vivo [Retraction]

Yang GH, Ren ZX, Yang X, Zhang YG

OncoTargets and Therapy 2023, 16:309-310

Published Date: 9 May 2023

Treating CD33-Positive de novo Acute Myeloid Leukemia in Pediatric Patients: Focus on the Clinical Value of Gemtuzumab Ozogamicin

Wijnen NE, Koedijk JB, Klein K, Luesink M, Goemans BF, Zwaan CM, Kaspers GJL

OncoTargets and Therapy 2023, 16:297-308

Published Date: 29 April 2023

MNK Proteins as Therapeutic Targets in Leukemia

Mazewski C, Platanias LC

OncoTargets and Therapy 2023, 16:283-295

Published Date: 21 April 2023

Evaluating Solid Lung Adenocarcinoma Anaplastic Lymphoma Kinase Gene Rearrangement Using Noninvasive Radiomics Biomarkers [Corrigendum]

Ma DN, Gao XY, Dan YB, Zhang AN, Wang WJ, Yang G, Zhu HZ

OncoTargets and Therapy 2023, 16:279-280

Published Date: 20 April 2023

Dihydrotanshinone I Inhibits the Growth of Osteosarcoma Through the Wnt/β-Catenin Signaling Pathway [Retraction]

Tan T, Chen J, Hu Y, Wang N, Chen Y, Yu T, Lin D, Yang S, Luo J, Luo X

OncoTargets and Therapy 2023, 16:275-276

Published Date: 12 April 2023

Ability of Blood Cell Parameters to Predict Clinical Outcomes of Nivolumab Monotherapy in Advanced Esophageal Squamous Cell Carcinoma

Hamai Y, Emi M, Ibuki Y, Kurokawa T, Yoshikawa T, Ohsawa M, Hirohata R, Kitasaki N, Okada M

OncoTargets and Therapy 2023, 16:263-273

Published Date: 10 April 2023

miR-302 Cluster Inhibits Angiogenesis and Growth of K562 Leukemia Cells by Targeting VEGFA [Retraction]

Cao J, Li L, Han X, Cheng H, Chen W, Qi K, Chen C, Wu Q, Niu M, Zeng L, Xu K

OncoTargets and Therapy 2023, 16:261-262

Published Date: 8 April 2023

Potential Therapeutic Targets for Luminal Androgen Receptor Breast Cancer: What We Know so Far

Stella S, Martorana F, Massimino M, Vitale SR, Manzella L, Vigneri P

OncoTargets and Therapy 2023, 16:235-247

Published Date: 7 April 2023

MicroRNA-143-3p Suppresses Tumorigenesis by Targeting Catenin-δ1 in Colorectal Cancer [Retraction]

Ding X, Du J, Mao K, Wang X, Ding Y, Wang F

OncoTargets and Therapy 2023, 16:233-234

Published Date: 6 April 2023

From Co-Stimulation to Co-Inhibition: A Continuum of Immunotherapy Care Toward Long-Term Survival in Melanoma

Simonetti E, Cutarella S, Valente M, Sani T, Ravara M, Maio M, Di Giacomo AM

OncoTargets and Therapy 2023, 16:227-232

Published Date: 5 April 2023

Efficacy and Safety of Nanosomal Docetaxel Lipid Suspension (NDLS) versus Conventional Docetaxel as Neoadjuvant and Adjuvant Therapy for Primary Operable Breast Cancer

Badiginchala R, Dattatreya PS, Suresh AVS, Nirni SS, Andra VV, Bunger D, Chaturvedi A

OncoTargets and Therapy 2023, 16:215-225

Published Date: 1 April 2023

Matrine Suppresses the Migration and Invasion of NSCLC Cells by Inhibiting PAX2-Induced Epithelial-Mesenchymal Transition [Retraction]

Yang J, He D, Peng Y, Zhong HZ, Deng YH, Yu Z, Guan C, Zuo Y, Xu Z

OncoTargets and Therapy 2023, 16:213-214

Published Date: 29 March 2023

CXCL8 Promotes Glioma Progression by Activating the JAK/STAT1/HIF-1α/Snail Signaling Axis [Retraction]

Chen Z, Mou L, Pan Y, Feng C, Zhang J, Li J

OncoTargets and Therapy 2023, 16:211-212

Published Date: 28 March 2023

Transmission of Exosomal TPX2 Promotes Metastasis and Resistance of NSCLC Cells to Docetaxel

Hu J, He Q, Tian T, Chang N, Qian L

OncoTargets and Therapy 2023, 16:197-210

Published Date: 27 March 2023

Role of Systemic Immunoinflammation Landscape in the Overall Survival of Patients with Leptomeningeal Metastases from Lung Cancer

Wang JW, Yuan Q, Li L, Cao KH, Liu Q, Wang HL, Hu K, Wu X, Wan JH

OncoTargets and Therapy 2023, 16:179-187

Published Date: 23 March 2023

A Review of CAR-T Therapy in Pediatric and Young Adult B-Lineage Acute Leukemia: Clinical Perspectives in Singapore

Seng MS, Meierhofer AC, Lim FL, Soh SY, Hwang WYK

OncoTargets and Therapy 2023, 16:165-176

Published Date: 14 March 2023

Clinical Efficacy and Safety of Immunotherapy Retreatment in Metastatic Cervical Cancer: A Retrospective Study

Li G, Cheng M, Hong K, Jiang Y

OncoTargets and Therapy 2023, 16:157-163

Published Date: 6 March 2023

Polatuzumab Vedotin in a Patient with Refractory Burkitt Lymphoma, a Case Report

Alanzi M, Abu-Tineh M, Szabados L, Sharaf Eldean M, Alatasi S, Taha RY, Elkourashy SA

OncoTargets and Therapy 2023, 16:133-139

Published Date: 21 February 2023

HER2-Directed Therapy in Advanced Breast Cancer: Benefits and Risks

Mandó P, Waisberg F, Pasquinelli R, Rivero S, Ostinelli A, Perazzo F

OncoTargets and Therapy 2023, 16:115-132

Published Date: 19 February 2023

Ineffectiveness of Crizotinib in a Non-Small-Cell Lung Cancer with Novel ALK- LIMS1 Fusion: A Case Report

Shi J, Jia Z, Zhou Z, Zhao L, Meng Q, Liu Y

OncoTargets and Therapy 2023, 16:109-114

Published Date: 17 February 2023

Recurrent Glioblastoma: Ongoing Clinical Challenges and Future Prospects

Pineda E, Domenech M, Hernández A, Comas S, Balaña C

OncoTargets and Therapy 2023, 16:71-86

Published Date: 25 January 2023

Alectinib-Induced Severe Hemolytic Anemia in a Patient with ALK-Positive Non-Small Cell Lung Cancer: A Case Report

Misawa K, Nakamichi S, Iida H, Nagano A, Mikami E, Tozuka T, Matsumoto M, Miyanaga A, Noro R, Kubota K, Yamaguchi H, Seike M

OncoTargets and Therapy 2023, 16:65-69

Published Date: 24 January 2023

A Primary Lung and Breast Cancer Patient with Germline EGFR R776H Mutation: A Case Report and Literature Review

Li D, Liu X, Cui S, Yang D, Zhu Y, Pan E, Yang P, Dai Z

OncoTargets and Therapy 2023, 16:17-22

Published Date: 18 January 2023

Post-Hematopoietic Cell Transplantation Relapsed Acute Lymphoblastic Leukemia: Current Challenges and Future Directions

Varadarajan I, Pierce E, Scheuing L, Morris A, El Chaer F, Keng M

OncoTargets and Therapy 2023, 16:1-16

Published Date: 14 January 2023

Overexpression of BCL2, BCL6, VEGFR1 and TWIST1 in Circulating Tumor Cells Derived from Patients with DLBCL Decreases Event-Free Survival

Cerón R, Martínez A, Ramos C, De la Cruz A, García A, Mendoza I, Palmeros G, Montaño Figueroa EH, Navarrete J, Jiménez-Morales S, Martinez-Murillo C, Olarte I

OncoTargets and Therapy 2022, 15:1583-1595

Published Date: 30 December 2022

Combination Use of First-Line Afatinib and Proton-Pump Inhibitors Reduces Overall Survival Among Patients with EGFFR Mutant Lung Cancer

Ho MC, Chung YS, Lin YC, Hung MS, Fang YH

OncoTargets and Therapy 2022, 15:1573-1582

Published Date: 28 December 2022

Spotlight on Targeted Chemotherapy in Retinoblastoma: Safety, Efficacy, and Patient Outcomes

Naseripour M, Mirshahi R, Kasraei H, Sedaghat A, Azimi F

OncoTargets and Therapy 2022, 15:1545-1561

Published Date: 22 December 2022

More articles